Unknown

Dataset Information

0

Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies.


ABSTRACT: Metabolic diseases have become a serious threat to human health worldwide. It is crucial to look for effective drugs from natural products to treat metabolic diseases. Curcumin, a natural polyphenolic compound, is mainly obtained from the rhizomes of the genus Curcuma. In recent years, clinical trials using curcumin for the treatment of metabolic diseases have been increasing. In this review, we provide a timely and comprehensive summary of the clinical progress of curcumin in the treatment of three metabolic diseases, namely type 2 diabetes mellitus (T2DM), obesity and non-alcoholic fatty liver disease (NAFLD). The therapeutic effects and underlying mechanisms of curcumin on these three diseases are presented categorically. Accumulating clinical evidence demonstrates that curcumin has good therapeutic potential and a low number of side effects for the three metabolic diseases. It can lower blood glucose and lipid levels, improve insulin resistance and reduce inflammation and oxidative stress. Overall, curcumin may be an effective drug for the treatment of T2DM, obesity and NAFLD. However, more high-quality clinical trials are still required in the future to verify its efficacy and determine its molecular mechanisms and targets.

SUBMITTER: Zeng Y 

PROVIDER: S-EPMC9959718 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies.

Zeng Yujiao Y   Luo Yuting Y   Wang Lijie L   Zhang Kun K   Peng Jiayan J   Fan Gang G  

International journal of molecular sciences 20230207 4


Metabolic diseases have become a serious threat to human health worldwide. It is crucial to look for effective drugs from natural products to treat metabolic diseases. Curcumin, a natural polyphenolic compound, is mainly obtained from the rhizomes of the genus <i>Curcuma</i>. In recent years, clinical trials using curcumin for the treatment of metabolic diseases have been increasing. In this review, we provide a timely and comprehensive summary of the clinical progress of curcumin in the treatme  ...[more]

Similar Datasets

| S-EPMC7023263 | biostudies-literature
| S-EPMC8746812 | biostudies-literature
| S-EPMC7141226 | biostudies-literature
| S-EPMC7706195 | biostudies-literature
| S-EPMC11828863 | biostudies-literature
| S-EPMC8704992 | biostudies-literature
| S-EPMC10515611 | biostudies-literature
| S-EPMC11747985 | biostudies-literature
| S-EPMC6017430 | biostudies-literature
| S-EPMC9988426 | biostudies-literature